Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Henk M. Verheul
The Effect of Everolimus and Low-Dose Cyclophosphamide on Immune Cell Subsets in Patients With Metastatic Renal Cell Carcinoma: Results From a Phase I Clinical Trial
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
Related publications
A Phase I/Ii Trial of BNC105P With Everolimus in Metastatic Renal Cell Carcinoma
Clinical Cancer Research
Cancer Research
Oncology
Phase I Trial of Sunitinib and Temsirolimus in Metastatic Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
Phase I Clinical Trial of Human Vascular Endothelial Growth Factor Receptor 1 Peptide Vaccines for Patients With Metastatic Renal Cell Carcinoma
British Journal of Cancer
Cancer Research
Oncology
Autologous Tumor Cell Vaccination Combined With Systemic CpG-B and IFN-α Promotes Immune Activation and Induces Clinical Responses in Patients With Metastatic Renal Cell Carcinoma: A Phase II Trial
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
Outcomes Based on Age in the Phase III METEOR Trial of Cabozantinib Versus Everolimus in Patients With Advanced Renal Cell Carcinoma
European Journal of Cancer
Cancer Research
Oncology
Clinical Impact of Targeted Therapies in Patients With Metastatic Clear-Cell Renal Cell Carcinoma
OncoTargets and Therapy
Oncology
Pharmacology
Everolimus in Metastatic Renal Cell Carcinoma : Preliminary Experience From Chang Gung Memorial Hospital
Biomedical Journal
Medicine
Phase II Trial of Capecitabine and Weekly Docetaxel in Metastatic Renal Cell Carcinoma
Urology
Urology
High-Dose Interleukin 2 in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid Features
PLoS ONE
Multidisciplinary
